Professor of Stroke Medicine
- Chief Executive Officer, Oxford Academic Health Science Network
- Consultant Stroke Physician OUH
My work focuses on developing and evaluating treatments that can reduce brain damage in the first few hours after stroke, and developing better processes of care to deliver for stroke patients.
I have developed and evaluated the performance of stroke recognition instruments such as the Face Arm Speech Test (FAST) and Recognition of Stroke in the Emergency Room Scale (ROSIER) to improve early diagnosis of stroke by the public, ambulance paramedics and Emergency Department teams.
My work has evaluated the risks and benefits of thrombolysis in very elderly stroke patients 80 years or older, who are the population at highest risk of stroke.
In addition to my research in stroke my work more broadly seeks to understand the risks and benefits of drug therapies in older people.
Sphenopalatine ganglion stimulation after stroke, promising but not yet ready for adoption
Sandset EC. and Ford GA., (2019), The Lancet, 394, 189 - 190
Safety and efficacy of co-careldopa as an add-on therapy to occupational and physical therapy in patients after stroke (DARS): a randomised, double-blind, placebo-controlled trial
Ford GA. et al, (2019), The Lancet Neurology, 18, 530 - 538
Delayed Revascularization in Patients With Basilar Artery Occlusion.
Dumont AS. and Ford GA., (2019), Stroke, 50, 1327 - 1328
Robot assisted training for the upper limb after stroke (RATULS): a multicentre randomised controlled trial.
Rodgers H. et al, (2019), Lancet
Glucose Modifies the Effect of Endovascular Thrombectomy in Patients With Acute Stroke.
Chamorro Á. et al, (2019), Stroke, 50, 690 - 696